Blood group genotyping in multi-transfused patients

Transfusion and Apheresis Science

Volumn 48, Issue 2, 2013, Pages 257-261

  Bakanay, Sule Mine ^a   Ozturk, Aysenur ^a   Ileri, Talia ^a   Ince, Elif ^a   Yavasoglu, Suzan ^a   Akar, Nejat ^a   Uysal, Zumrut ^a   Arslan, Onder ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Alloimmunization; Blood groups; Genotyping; Thalassemia; Transfusion

Indexed keywords

RHESUS D ANTIBODY;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HEMAGGLUTINATION; HUMAN; INFANT; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SICKLE CELL ANEMIA; THALASSEMIA;

ADOLESCENT; ADULT; AGED; ALLELES; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED;

EID: 84877617708     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.01.009     Document Type: Article

References (42)

1. Singer S.T., Wu V., Mignacca R., Kuypers F.A., Morel P., Vichinsky E.P. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 2000, 96:3369-3373.
2. Wang L.Y., Liang D.C., Liu H.C., Chang F.C., Wang C.L., Chan Y.S., et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006, 16:200-203.
3. Karimi M., Nikrooz P., Kashef S., Jamalian N., Davatolhagh Z. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran. Int J Lab Hematol 2007, 29:321-326.
4. Canatan D., Karadogan C., Oguz N., Balta N., Cosan R., Ozsancak A., et al. Red cell antibodiesin patient with Beta-thalassemia major. Blood Bank Transfus Med 2003, 1:121-123.
5. Vichinsky E.P., Earles A., Johnson R.A., Hoag M.S., Williams A., Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New Engl J Med 1990, 322:1617-1621.
6. Smith-Whitley K. Alloimmunization in patients with sickle cell disease. Pediatric transfusion therapy 2002, AABB Press, Bethesda. C.S. Manno (Ed.).
7. Hillyer C.D., Shaz B.H., Winkler A.M., Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008, 22:117-132.
8. Daniels G. The molecular genetics of blood group polymorphism. Hum Genet 2009, 126:729-742.
9. Cartron J.P., Colin Y. Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001, 8:163-199.
10. Daniels G.L., Fletcher A., Garratty G., Henry S., Jørgensen J., Judd W.J., et al. Blood group terminology 2004: from the international society of blood transfusion committee on terminology for red cell surface antigens. Vox Sang 2004, 87:304-316.
11. Daniels G.L., Flegel W.A., Fletcher A., Garratty G., Levene C., Lomas-Francis C., et al. International society of blood transfusion committee on terminology for red cell surface antigens: cape town report. Vox Sang 2007, 92:250-253.
12. Smythe J.S., Avent N.D., Judson P.A., Parsons S.F., Martin P.G., Anstee D.J. Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood 1996, 87:2968-2973.
13. Wagner F.F., Flegel W.A. RHD gene deletion occurred in the Rhesusbox. Blood 2000, 95:3662-3668.
14. Singleton B.K., Green C.A., Avent N.D., Martin P.G., Smart E., Daka A., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in most Africans with the Rh D-negative blood group phenotype. Blood 2000, 95:12-18.
15. Faas B.H.W., Beckers E.A.M., Wildoer P., Ligthart P.C., Overbeeke M.A., Zondervan H.A., et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997, 37:38-44.
16. Daniels G.L., Faas B.H.W., Green C.A., Smart E., Maaskant-van Wijk P.A., Avent N.D., et al. The Rh VS and V blood group polymorphisms in Africans: a serological and molecular analysis. Transfusion 1998, 38:951-958.
17. Anstee D.J. Red cell genotyping and the future of pretransfusion testing. Blood 2009, 114:248-256.
18. Flegel W.A. Molecular genetics of RH and its clinical application. Transfus Clin Biol 2006, 13:4-12.
19. Mouro I., Colin Y., Chérif-Zahar B., Cartron J.P., Le Van Kim C. Molecular genetic basis of the human Rhesus blood group system. Nat Genet 1993, 5:62-65.
20. Simsek S., de Jong C.A., Cuijpers H.T., Bleeker P.M., Westers T.M., Overbeeke M.A., et al. Sequence analysis of cDNA derived from reticulocyte mRNAs coding for Rh polypeptides and demonstration of E/e and C/c polymorphisms. Vox Sang 1994, 67:203-209.
21. Lee S., Zambas E., Green E.D., Redman C. Organization of the gene encoding the human Kell blood group protein. Blood 1995, 85:1364-1370.
22. Olivès B., Merriman M., Bailly P., Bain S., Barnett A., Todd J., et al. The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. Hum Mol Genet 1997, 6:1017-1020.
23. Chaudhuri A., Polyakova J., Zbrzezna V., Pogo A.O. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995, 85:615-621.
24. Mallinson G., Soo K.S., Schall T.J., Pisacka M., Anstee D.J. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995, 90:823-829.
25. Legler T.J., Eber S.W., Lakomek M., Lynen R., Maas J.H., Pekrun A., et al. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999, 39:852-855.
26. Castilho L., Rios M., Bianco C., Pellegrino J.J.R., Alberto F.L., Saad S.T., Costa F.F. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion 2002, 42:232-238.
27. Guelsin G.A., Sell A.M., Castilho L., Masaki V.L., Melo F.C., Hashimoto M.N., et al. Benefits of blood group genotyping in multi-transfused patients from the south of Brazil. J Clin Lab Anal 2010, 24:311-316.
28. Ribeiro K.R., Guarnieri M.H., da Costa D.C., Costa F.F., Pellegrino J.J.R., Castilho L. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009, 97:147-152.
29. Davis L.G., Dibner M.D., Battey J.F. Basic methods in molecular biology 1986, Elsevier Science, New York.
30. BAGene DNA-SSP Kits. BAG Health Care GmbH: Lich, Germany; 2009 [instruction book].
31. Prager M. Molecular genetic blood group typing by the use of PCR-SSP technique. Transfusion 2007, 47. 54S-9S.
32. Rozman P., Dovc T., Gassner C. Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions. Transfusion 2000, 40:936-942.
33. Reid M.E., Rios M., Powell V.I., Charles-Pierre D., Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000, 40:48-53.
34. Tournamille C., Colin Y., Cartron J.P., Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995, 10:224-228.
35. Canatan D., Acar N., Ki{dotless}li{dotless}c B. Rh subgroups and Kell antigens in patients with thalassemia and donors in Turkey. Turk J Med Sci 1999, 29:155-157.
36. Castilho L., Rios M., Pellegrino J., Costa F. Blood group genotyping facilitates transfusion of beta-thalassemia patients. J Clin Lab Anal 2002, 16:216-220.
37. Luban N.L. Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. Am J Pediatr Hematol Oncol 1989, 11:314-319.
38. Olujohungbe A., Hambleton I., Stephens L., Serjeant B., Sergeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001, 113:661-665.
39. Hendrickson J.E., Chadwick T.E., Roback J.D., Hillyer C.D., Zimring J.C. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007, 110:2736-2743.
40. Higgins J.M., Sloan S.R. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunological responders. Blood 2008, 112:2546-2553.
41. Altay C. The frequency and distribution of β-thalassemia mutations in Turkey. Turk J Hematol 2002, 19:309-315.
42. Thalassemia International Federation. Guidelines for the clinical management of thalassemia. 2nd ed; 2008 http://www.thalassemia.org.cy.